Subsequent investigations have highlighted potent and structurally diverse MTH1 inhibitors (MTH1i) that engage MTH1 in cells but cannot reproduce the anti-cancer activity of earlier molecules (Fig. 3a)33–35. Here, NUDT1 is linked to cancer.